Temocillin Versus a Carbapenem as Initial Intravenous Treatment for ESBL Related Urinary Tract Infections
Clinical trial NCT03543436 · COMPLETED
Trial details
- NCT number
- NCT03543436
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-04
- Primary completion
- 2020-10-29
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.